Hospital Staff Must Watch Jaundice More Carefully
CHICAGO-"Drive-thru" deliveries may be responsible for an increase in a rare condition that causes brain damage. Babies who are sent home a day after birth may not be treated for jaundice, which can lead to kernicterus.
Kernicterus, which was common in the 1940s and 1950s, has become rare in the last several decades. The condition can cause several cerebral palsy, hearing loss, teeth malformations, and other malformations.
Kernicertus is caused when the brain receives too many bilirubin cells. The liver is supposed to filter these cells out of the blood stream; however, most infants' livers do not begin working for several days after their birth. Jaundice, which is causes a yellowing of the skin, involves an elevated level of bilirubin. Jaundiced babies are often placed under fluorescent lights that make these cells more easily filtered by the liver.
Babies sent home healthy may still develop jaundice. If untreated, this can cause kernicertus.
Doctors are not certain how bilirubin damages the brain, but autopsies of infants with the disease have found yellow staining the region of the brain that controls movement. Kernicterus is not monitored by the Centers for Disease Control and Prevention (CDC), however the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) is asking healthcare workers to monitor jaundice more carefully to protect infants. The commission recommends that all newborns with jaundice receive medical follows-ups within two days after being sent home. Parents should also be educated about jaundice and the risks associated.
Information from www.arizonarepublic.com
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
